References
- LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death xfor 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
- LibbyPTherouxPPathophysiology of coronary artery diseaseCirculation2005111253481348815983262
- CichaIGarlichsCDAlexiouCCardiovascular therapy through nanotechnology – how far are we still from bedside?Eur J Nanomed2014626387
- ThoratNDBoharaRAYadavHMTofailSAMMulti-modal MR imaging and magnetic hyperthermia study of Gd doped Fe3O4 nanoparticles for integrative cancer therapyRSC Adv20166979496794975
- LyerSTietzeRJurgonsRVisualisation of tumour regression after local chemotherapy with magnetic nanoparticles – a pilot studyAnticancer Res20103051553155720592340
- TietzeRLyerSDürrSEfficient drug-delivery using magnetic nanoparticles – biodistribution and therapeutic effects in tumour bearing rabbitsNanomedicine20139796197123669367
- JankoCDürrSMunozLEMagnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytesInt J Mol Sci20131447341735523549268
- MaYHWuSYWuTChangYJHuaMYChenJPMagnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticlesBiomaterials200930193343335119299010
- ZhangYLiWOuLTargeted delivery of human VEGF gene via complexes of magnetic nanoparticle-adenoviral vectors enhanced cardiac regenerationPLoS One201277e3949022844395
- ChaoXZhangZGuoLA novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapyPLoS One2012710e4038823056167
- ElbialyNSFathyMMKhalilWMDoxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug deliveryInt J Pharm20154901–219019925997662
- YuJJuYZhaoLMultistimuli-regulated photochemothermal cancer therapy remotely controlled via Fe5C2 nanoparticlesACS Nano201610115916926602632
- ByrneJDBetancourtTBrannon-PeppasLActive targeting schemes for nanoparticle systems in cancer therapeuticsAdv Drug Deliv Rev200860151615162618840489
- MaHLQiXRDingWXMaitaniYNagaiTMagnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticlesJ Biomed Mater Res A200884359860617618488
- ChenHKaminskiMDPytelPMacdonaldLRosengartAJCapture of magnetic carriers within large arteries using external magnetic fieldsJ Drug Target200816426226818446604
- RichterHWiekhorstFSchwarzKMagnetorelaxometric quantification of magnetic nanoparticles in an artery model after ex vivo magnetic drug targetingPhys Med Biol20095418N417N42419700820
- JanikowskaAMatuszakJLyerSA novel human artery model to assess the magnetic accumulation of SPIONs under flow conditionsSci Rep201774231428176885
- TietzeRRahnHLyerSVisualization of superparamagnetic nanoparticles in vascular tissue using XµCT and histologyHistochem Cell Biol2011135215315821279377
- PolyakBMedvedMLazarevaNMagnetic nanoparticle-mediated targeting of cell therapy reduces in-stent stenosis in injured arteriesACS Nano2016101095599569
- FlammerJRRogatskyIMinireview: Glucocorticoids in autoimmunity: unexpected targets and mechanismsMol Endocrinol20112571075108621511881
- JiJYJingHDiamondSLShear stress causes nuclear localization of endothelial glucocorticoid receptor and expression from the GRE promoterCirc Res200392327928512595339
- LobattoMECalcagnoCOttenMJPharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapyNanomedicine20151151133114025791805
- HadokePWIqbalJWalkerBRTherapeutic manipulation of glucocorticoid metabolism in cardiovascular diseaseBr J Pharmacol2009156568971219239478
- HämäläinenMNieminenRUurtoIDexamethasone-eluting vascular stentsBasic Clin Pharmacol Toxicol2013112529630123374962
- RibichiniFTomaiFPalosciaLSteroid-eluting stents in patients with acute coronary syndrome: the dexamethasone eluting stent Italian registryHeart200793559860017005712
- HoffmannRRadkePWOrtleppJRIntravascular ultrasonic comparative analysis of degree of intimal hyperplasia produced by four different stents in the coronary arteriesAm J Cardiol200494121548155015589014
- HanSHAhnTHKangWCThe favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective studyAm Heart J20061525887.e1887.e7
- KönigALeibigMRieberJRandomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: serial angiographic and sonographic analysisAm Heart J20071536979.e1979.e817540198
- ParkYMHanSHLeeKDexamethasone-eluting stents had sustained favorable ischemic driven target lesion revascularization rates over 5 years: a randomized controlled prospective studyInt J Cardiol2013165235936222974726
- ReilTDSarkarRKashyapVSSarkarMGelabertHADexamethasone suppresses vascular smooth muscle cell proliferationJ Surg Res199985110911410383846
- ZalogaJJankoCNowakJDevelopment of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibilityInt J Nanomedicine201494847486625364244
- MatuszakJBaumgartnerJZalogaJNanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testingNanomedicine201611659761627003004
- BuechlerCRitterMOrsóELangmannTKluckenJSchmitzGRegulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuliJ Leukoc Biol20006719710310648003
- GordonDKobernickSDMcmillanGCDuffGLThe effect of cortisone on the serum lipids and on the development of experimental cholesterol atherosclerosis in the rabbitJ Exp Med195499437138613152282
- NaitoMYasueMAsaiKEffects of dexamethasone on experimental atherosclerosis in cholesterol-fed rabbitsJ Nutr Sci Vitaminol19923832552641453236
- van der ValkFMSchulteDMMeilerSLiposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosisNanomedicine20161261463147027015770
- MccollAMichlewskaSDransfieldIRossiAGEffects of glucocorticoids on apoptosis and clearance of apoptotic cellsSci World J2007711651181
- YangLYangJBChenJEnhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasoneCell Res200414431532315353128
- JohnsDGDorranceAMTramontiniNLWebbRCGlucocorticoids inhibit tetrahydrobiopterin-dependent endothelial functionExp Biol Med200122612731
- IuchiTAkaikeMMitsuiTGlucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunctionCirc Res2003921818712522124
- VoisardRSeitzerUBaurRCorticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitroInt J Cardiol19944332572678181884
- van PutDJvan HoveCEde MeyerGRWuytsFHermanAGBultHDexamethasone influences intimal thickening and vascular reactivity in the rabbit collared carotid arteryEur J Pharmacol19952942–37537618750742
- FlorianALudwigARöschSPositive effect of intravenous iron-oxide administration on left ventricular remodelling in patients with acute ST-elevation myocardial infarction – a cardiovascular magnetic resonance (CMR) studyInt J Cardiol2014173218418924613367
- ThoratNDBoharaRANoorMRDhamechaDSoulimaneTTofailSAMEffective cancer theranostics with polymer encapsulated superparamagnetic nanoparticles: combined effects of magnetic hyperthermia and controlled drug releaseACS Biomater Sci Eng20173713321340